BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mellinger JL, Shedden K, Winder GS, Tapper E, Adams M, Fontana RJ, Volk ML, Blow FC, Lok ASF. The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology 2018;68:872-82. [PMID: 29579356 DOI: 10.1002/hep.29887] [Cited by in Crossref: 106] [Cited by in F6Publishing: 97] [Article Influence: 26.5] [Reference Citation Analysis]
Number Citing Articles
1 Deutsch-Link S, Curtis B, Singal AK. Covid-19 and alcohol associated liver disease. Dig Liver Dis 2022:S1590-8658(22)00586-2. [PMID: 35933291 DOI: 10.1016/j.dld.2022.07.007] [Reference Citation Analysis]
2 Rattan P, Shah VH. Review article: current and emerging therapies for acute alcohol-associated hepatitis. Aliment Pharmacol Ther 2022;56:28-40. [PMID: 35567372 DOI: 10.1111/apt.16969] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Julien J, Ayer T, Tapper EB, Barbosa C, Dowd WN, Chhatwal J. Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: A modeling study. Hepatology 2022;75:1480-90. [PMID: 34878683 DOI: 10.1002/hep.32272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Tapper EB, Ufere NN, Huang DQ, Loomba R. Review article: current and emerging therapies for the management of cirrhosis and its complications. Aliment Pharmacol Ther 2022;55:1099-115. [PMID: 35235219 DOI: 10.1111/apt.16831] [Reference Citation Analysis]
5 Cabezas J. Management of Alcohol-Related Liver Disease and Its Complications. Clin Drug Investig 2022. [PMID: 35467296 DOI: 10.1007/s40261-022-01143-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Leggio L, Mellinger JL. Alcohol use disorder in community management of chronic liver diseases. Hepatology 2022. [PMID: 35434815 DOI: 10.1002/hep.32531] [Reference Citation Analysis]
7 Haque LY, Fiellin DA. Bridging the Gap: Dual Fellowship Training in Addiction Medicine and Digestive Diseases. Dig Dis Sci. [DOI: 10.1007/s10620-022-07478-9] [Reference Citation Analysis]
8 Singal AK, Kwo P, Kwong A, Liangpunsakul S, Louvet A, Mandrekar P, McClain C, Mellinger J, Szabo G, Terrault N, Thursz M, Winder GS, Kim WR, Shah VH. Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease. Hepatology 2022;75:1026-37. [PMID: 34496071 DOI: 10.1002/hep.32143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tapper EB, Essien UR, Zhao Z, Ufere NN, Parikh ND. Racial and ethnic disparities in rifaximin use and subspecialty referrals for patients with hepatic encephalopathy in the United States. J Hepatol 2022:S0168-8278(22)00116-7. [PMID: 35367057 DOI: 10.1016/j.jhep.2022.02.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Meza V, Arnold J, Díaz LA, Ayala Valverde M, Idalsoaga F, Ayares G, Devuni D, Arab JP. Alcohol Consumption: Medical Implications, the Liver and Beyond. Alcohol Alcohol 2022:agac013. [PMID: 35333295 DOI: 10.1093/alcalc/agac013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Tapper EB, Zhao Z, Mazumder N, Parikh ND. Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans. Dig Dis Sci 2022. [PMID: 35262903 DOI: 10.1007/s10620-022-07454-3] [Reference Citation Analysis]
12 Tapper EB, Zhao Z, Winder GS, Parikh ND. Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kichloo A, El-Amir Z, Dahiya DS, Wani F, Singh J, Solanki D, Edigin E, Eseaton P, Mehboob A, Shaka H. Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissions. World J Hepatol 2021; 13(12): 2128-2136 [DOI: 10.4254/wjh.v13.i12.2128] [Reference Citation Analysis]
14 Huang AC, Grab J, Flemming JA, Dodge JL, Irani RA, Sarkar M. Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes. Am J Gastroenterol 2021. [PMID: 34928866 DOI: 10.14309/ajg.0000000000001590] [Reference Citation Analysis]
15 Hwang CL, Phillips SA, Tu MH, Piano MR. Time to Promote the Awareness of Unhealthy Alcohol Use Among Women. J Womens Health (Larchmt) 2021. [PMID: 34935470 DOI: 10.1089/jwh.2021.0546] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Winters AC, Aby ES, Fix OK, German M, Haque LYK, Im GY. Joining the Fight: Enhancing Alcohol Treatment Education in Hepatology. Clin Liver Dis (Hoboken) 2021;18:225-9. [PMID: 34840723 DOI: 10.1002/cld.1127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Arab JP, Izzy M, Leggio L, Bataller R, Shah VH. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34725498 DOI: 10.1038/s41575-021-00527-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
18 Kposowa AJ, Breault K. Disability Status, Unemployment, and Alcohol-Related Liver Disease (ALD) Mortality: A Large Sample Individual Level Longitudinal Study. Subst Abuse Rehabil 2021;12:81-8. [PMID: 34703353 DOI: 10.2147/SAR.S334851] [Reference Citation Analysis]
19 Burkholder DA, Moran IJ, DiBattista JV, Lok AS, Parikh ND, Chen VL. Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications. Dig Dis Sci 2021. [PMID: 34674069 DOI: 10.1007/s10620-021-07282-x] [Reference Citation Analysis]
20 Mikolajczyk AE, Zilberstein N, McConville JF, Pan A, Aronsohn AI, Te HS, Reddy G, Paul S, Pillai A, Charlton M, Farnan JM. Mandatory Hepatology Education for Internal Medicine Residents: Long-Term Effects and Implications for Workforce Needs. Hepatol Commun 2021;5:1953-63. [PMID: 34558840 DOI: 10.1002/hep4.1792] [Reference Citation Analysis]
21 Makar M, Reja D, Chouthai A, Kabaria S, Patel AV. The impact of acute kidney injury on mortality and clinical outcomes in patients with alcoholic cirrhosis in the USA. Eur J Gastroenterol Hepatol. 2021;33:905-910. [PMID: 32976187 DOI: 10.1097/meg.0000000000001947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Fan X, Huang X, Hershman M, Zheng X, Jiang C, Yue B, Weisberg I. Portal vein thrombosis prevalence and mortality among alcoholic cirrhosis in a nationwide inpatient cohort. Eur J Gastroenterol Hepatol 2020;32:1160-7. [PMID: 31834054 DOI: 10.1097/MEG.0000000000001624] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Simon TG, Patorno E, Schneeweiss S. Glucose-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00724-2. [PMID: 34256144 DOI: 10.1016/j.cgh.2021.07.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
24 Mahmud N, Fricker Z, Lewis JD, Taddei TH, Goldberg DS, Kaplan DE. Risk Prediction Models for Postoperative Decompensation and Infection in Patients With Cirrhosis: A Veterans Affairs Cohort Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00721-7. [PMID: 34246794 DOI: 10.1016/j.cgh.2021.06.050] [Reference Citation Analysis]
25 Shirazi F, Singal AK, Wong RJ. Alcohol-associated Cirrhosis and Alcoholic Hepatitis Hospitalization Trends in the United States. J Clin Gastroenterol 2021;55:174-9. [PMID: 32520887 DOI: 10.1097/MCG.0000000000001378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kim Y, Reddy S, Mouchli M, Summey R, Walsh C, Mir A, Bierle L, Rubio M. Gender-Specific Risk Factors Contributing to Mortality in Patients Hospitalized With Alcoholic Cirrhosis. Cureus 2021;13:e16271. [PMID: 34377607 DOI: 10.7759/cureus.16271] [Reference Citation Analysis]
27 Chen PH, Ting PS, Almazan E, Chander G, Cameron AM, Gurakar A. Inter-Hospital Escalation-of-Care Referrals for Severe Alcohol-Related Liver Disease with Recent Drinking During the COVID-19 Pandemic. Alcohol Alcohol 2021:agab047. [PMID: 34219147 DOI: 10.1093/alcalc/agab047] [Reference Citation Analysis]
28 Connoley D, Patel PJ, Hogan B, Tanwar S, Rhodes F, Parkes J, Burt A, Watkins J, Sievert W, Rosenberg W. The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study. BMC Gastroenterol 2021;21:268. [PMID: 34182924 DOI: 10.1186/s12876-021-01795-5] [Reference Citation Analysis]
29 Kwon HC, Sohn H, Kim DH, Shin DM, Jeong CH, Chang YH, Yune JH, Kim YJ, Kim DW, Kim SH, Han SG. In Vitro and In Vivo Study on the Toxic Effects of Propiconazole Fungicide in the Pathogenesis of Liver Fibrosis. J Agric Food Chem 2021;69:7399-408. [PMID: 34170130 DOI: 10.1021/acs.jafc.1c01086] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Jo HH, Min C, Kyoung DS, Park MA, Kim SG, Kim YS, Chang Y, Jeong SW, Jang JY, Lee SH, Kim HS, Jun BG, Kim YD, Cheon GJ, Yoo JJ. Adverse outcomes after surgeries in patients with liver cirrhosis among Korean population: A population-based study. PLoS One 2021;16:e0253165. [PMID: 34125860 DOI: 10.1371/journal.pone.0253165] [Reference Citation Analysis]
31 Moon AM, Curtis B, Mandrekar P, Singal AK, Verna EC, Fix OK. Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation. Hepatol Commun 2021. [PMID: 34222743 DOI: 10.1002/hep4.1747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Han S, Yang Z, Zhang T, Ma J, Chandler K, Liangpunsakul S. Epidemiology of Alcohol-Associated Liver Disease. Clin Liver Dis 2021;25:483-92. [PMID: 34229835 DOI: 10.1016/j.cld.2021.03.009] [Reference Citation Analysis]
33 Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci 2021;22:5170. [PMID: 34068269 DOI: 10.3390/ijms22105170] [Reference Citation Analysis]
34 Haque L, Rosenheck R. Mental health and addiction service use among United States veterans with liver disease nationally in the Veterans Health Administration. JPMH 2021;20:191-200. [DOI: 10.1108/jpmh-07-2020-0088] [Reference Citation Analysis]
35 Asrani SK, Mellinger J, Arab JP, Shah VH. Reducing the Global Burden of Alcohol-Associated Liver Disease: A Blueprint for Action. Hepatology 2021;73:2039-50. [PMID: 32986883 DOI: 10.1002/hep.31583] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 17.0] [Reference Citation Analysis]
36 Mellinger JL, Winder GS, Fernandez AC, Klevering K, Johnson A, Asefah H, Figueroa M, Buchanan J, Blow F, Lok ASF. Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic. J Subst Abuse Treat 2021;130:108396. [PMID: 34118717 DOI: 10.1016/j.jsat.2021.108396] [Reference Citation Analysis]
37 Silva J, Carry E, Xue C, Zhang J, Liang J, Roberge JY, Davies DL. A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice. Molecules 2021;26:1791. [PMID: 33810134 DOI: 10.3390/molecules26061791] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Rustgi VK, Li Y, Gupta K, Minacapelli CD, Bhurwal A, Catalano C, Elsaid MI. Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity. Gastroenterology 2021;161:171-184.e10. [PMID: 33744305 DOI: 10.1053/j.gastro.2021.03.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
39 Shen NT, Kaplan A, Fahoum K, Basu E, Shenoy A, Wahid N, Ivatorov A, Pisa J, Salajegheh A, Dawod E, Rosenblatt R, Fortune B, Safford M, Brown RS Jr. Identification of Quantifiable Predictors of Relapse in Patients with Alcohol-Associated Liver Disease. Hepatol Commun 2021;5:1156-64. [PMID: 34278166 DOI: 10.1002/hep4.1704] [Reference Citation Analysis]
40 Silva J, Spatz MH, Folk C, Chang A, Cadenas E, Liang J, Davies DL. Dihydromyricetin improves mitochondrial outcomes in the liver of alcohol-fed mice via the AMPK/Sirt-1/PGC-1α signaling axis. Alcohol 2021;91:1-9. [PMID: 33080338 DOI: 10.1016/j.alcohol.2020.10.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
41 Mellinger JL, Shedden K, Winder GS, Fernandez AC, Lee BP, Waljee J, Fontana R, Volk ML, Blow FC, Lok ASF. Bariatric surgery and the risk of alcohol-related cirrhosis and alcohol misuse. Liver Int 2021;41:1012-9. [PMID: 33529460 DOI: 10.1111/liv.14805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Tapper EB, Baki J, Nikirk S, Hummel S, Asrani SK, Lok AS. Medically tailored meals for the management of symptomatic ascites: the SALTYFOOD pilot randomized clinical trial. Gastroenterol Rep (Oxf) 2020;8:453-6. [PMID: 33442478 DOI: 10.1093/gastro/goaa059] [Reference Citation Analysis]
43 Cam I, Gencturk M, Lim N, Sharma S, Wong J, Yang M, Golzarian J, Flanagan S, Young S. Alcohol Recidivism Following Transjugular Intrahepatic Portosystemic Shunt Placement: Frequency and Predictive Factors. Cardiovasc Intervent Radiol 2021;44:758-65. [PMID: 33415418 DOI: 10.1007/s00270-020-02754-5] [Reference Citation Analysis]
44 Asgharpour A, Dinani A, Friedman SL. Basic science to clinical trials in non-alcoholic fatty liver disease and alcohol-related liver disease: collaboration with industry. Transl Gastroenterol Hepatol 2021;6:5. [PMID: 33409399 DOI: 10.21037/tgh.2020.01.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Avanceña ALV, Miller N, Uttal SE, Hutton DW, Mellinger JL. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis. J Hepatol 2021;74:1286-94. [PMID: 33326815 DOI: 10.1016/j.jhep.2020.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
46 Bloom PP, Tapper EB. The Use of Administrative Data to Investigate the Population Burden of Hepatic Encephalopathy. J Clin Med 2020;9:E3620. [PMID: 33182743 DOI: 10.3390/jcm9113620] [Reference Citation Analysis]
47 Tapper EB, Parikh ND, Liangpunsakul S. Attacking Alcohol-Related Liver Disease by Taxing Alcohol Sales. Alcohol Clin Exp Res 2021;45:51-3. [PMID: 33164216 DOI: 10.1111/acer.14500] [Reference Citation Analysis]
48 Kennedy P, Bane O, Hectors SJ, Fischman A, Schiano T, Lewis S, Taouli B. Noninvasive imaging assessment of portal hypertension. Abdom Radiol (NY) 2020;45:3473-95. [PMID: 32926209 DOI: 10.1007/s00261-020-02729-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
49 Sequeira SB, Labaran LA, Bell JE, Amin RM, Rao SS, Werner BC. Compensated Cirrhosis Is Associated With Increased Risk of Complications Following Total Hip Arthroplasty in a Large Medicare Database. J Arthroplasty 2021;36:1361-1366.e1. [PMID: 33121848 DOI: 10.1016/j.arth.2020.10.008] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Mellinger JL, Stine JG. Early Liver Transplantation for Severe Alcoholic Hepatitis. Dig Dis Sci 2020;65:1608-14. [PMID: 32107678 DOI: 10.1007/s10620-020-06159-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
51 Im GY, Mellinger JL, Winters A, Aby ES, Lominadze Z, Rice J, Lucey MR, Arab JP, Goel A, Jophlin LL, Sherman CB, Parker R, Chen PH, Devuni D, Sidhu S, Dunn W, Szabo G, Singal AK, Shah VH. Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31439-7. [PMID: 33069880 DOI: 10.1016/j.cgh.2020.10.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
52 Shen NT, Bray J, Wahid NA, Raver M, Hutchison N, Brown RS Jr, Schackman BR. Evaluation of Alcohol Taxes as a Public Health Opportunity to Reduce Liver Transplant Listings for Alcohol-Related Liver Disease. Alcohol Clin Exp Res 2020;44:2307-15. [PMID: 32944958 DOI: 10.1111/acer.14454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 McElroy LM, Likhitsup A, Scott Winder G, Saeed N, Hassan A, Sonnenday CJ, Fontana RJ, Mellinger J. Gender Disparities in Patients With Alcoholic Liver Disease Evaluated for Liver Transplantation. Transplantation 2020;104:293-8. [PMID: 31283683 DOI: 10.1097/TP.0000000000002843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 Chen J, Argemi J, Odena G, Xu MJ, Cai Y, Massey V, Parrish A, Vadigepalli R, Altamirano J, Cabezas J, Gines P, Caballeria J, Snider N, Sancho-Bru P, Akira S, Rusyn I, Gao B, Bataller R. Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension. Sci Rep 2020;10:15558. [PMID: 32968110 DOI: 10.1038/s41598-020-72172-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
55 Elsaid MI, Li Y, Catalano C, Minacapelli CD, Gupta K, Rustgi VK. Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States. Pharmacoecon Open 2021;5:89-100. [PMID: 32897528 DOI: 10.1007/s41669-020-00229-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Da BL, Im GY, Schiano TD. Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease. Hepatology 2020;72:1102-8. [PMID: 32369624 DOI: 10.1002/hep.31307] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 47.0] [Reference Citation Analysis]
57 Osho A, Rich NE, Singal AG. Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response. Hepatoma Res 2020;6:55. [PMID: 32944652 DOI: 10.20517/2394-5079.2020.42] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Ladhani S, Hirode G, Singal AK, Wong RJ. Impact of Safety-Net Burden on In-Hospital Mortality and Hospitalization Costs Among Patients with Alcoholic Hepatitis and Alcoholic Cirrhosis. Alcohol and Alcoholism 2021;56:368-75. [DOI: 10.1093/alcalc/agaa081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Julien J, Ayer T, Bethea ED, Tapper EB, Chhatwal J. Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study.Lancet Public Health. 2020;5:e316-e323. [PMID: 32504584 DOI: 10.1016/S2468-2667(20)30062-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
60 Bell JE, Amin R, Labaran LA, Sequeira SB, Rao SS, Werner BC. Impact of Compensated Cirrhosis Etiology on Postoperative Outcomes Following Total Knee Arthroplasty. J Arthroplasty 2021;36:148-153.e1. [PMID: 32739079 DOI: 10.1016/j.arth.2020.07.019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Simonetto DA, Shah VH, Kamath PS. Outpatient management of alcohol-related liver disease. Lancet Gastroenterol Hepatol 2020;5:485-93. [PMID: 32277901 DOI: 10.1016/S2468-1253(19)30415-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
62 Lee HF, Chan YH, Chang SH, Tu HT, Chen SW, Yeh YH, Wu LS, Kuo CF, Kuo CT, See LC. Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation. J Am Heart Assoc 2019;8:e011112. [PMID: 30834802 DOI: 10.1161/JAHA.118.011112] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
63 Maddur H, Shah VH. Alcohol and Liver Function in Women. Alcohol Res 2020;40:10. [PMID: 32685339 DOI: 10.35946/arcr.v40.2.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Bertha M, Maddur H. Highlights From the AASLD/EASL ALD Endpoints Conference 2019. Clinical Liver Disease 2020;15:215-8. [DOI: 10.1002/cld.927] [Reference Citation Analysis]
65 Bansal MB. How Hepatologists Can Contribute to Value-Based Care. Clin Gastroenterol Hepatol 2020;18:2153-7. [PMID: 32562890 DOI: 10.1016/j.cgh.2020.06.026] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Carbonneau M, Eboreime EA, Hyde A, Campbell-scherer D, Faris P, Gramlich L, Tsuyuki RT, Congly SE, Shaheen AA, Sadler M, Zeman M, Spiers J, Abraldes JG, Sugars B, Sia W, Green L, Abdellatif D, Schaefer JP, Selvarajah V, Marr K, Ryan D, Westra Y, Bakshi N, Varghese JC, Tandon P. The cirrhosis care Alberta (CCAB) protocol: implementing an evidence-based best practice order set for the management of liver cirrhosis - a hybrid type I effectiveness-implementation trial. BMC Health Serv Res 2020;20. [DOI: 10.1186/s12913-020-05427-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Volk ML. Burden of Cirrhosis on Patients and Caregivers. Hepatol Commun 2020;4:1107-11. [PMID: 32766471 DOI: 10.1002/hep4.1526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
68 Esmaeili A, Yu W, Cucciare MA, Combs AS, Joshi G, Humphreys K. Budget Impact Analysis of a Computer-Delivered Brief Alcohol Intervention in Veterans Affairs (VA) Liver Clinics: A Randomized Controlled Trial. Alcoholism Treatment Quarterly 2020;38:515-31. [DOI: 10.1080/07347324.2020.1760755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Tapper EB, Aberasturi D, Zhao Z, Hsu CY, Parikh ND. Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis. Aliment Pharmacol Ther 2020;51:1397-405. [PMID: 32363684 DOI: 10.1111/apt.15749] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
70 Elsaid MI, John T, Li Y, Pentakota SR, Rustgi VK. The Health Care Burden of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:263-75. [DOI: 10.1016/j.cld.2020.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
71 Elsaid MI, Rustgi VK. Epidemiology of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:157-74. [DOI: 10.1016/j.cld.2020.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
72 Aye L, Volk ML. Discussion: Hospital readmissions in cirrhosis and the importance of treating alcohol use disorder. Dig Liver Dis 2020;52:788-9. [PMID: 32370934 DOI: 10.1016/j.dld.2020.03.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Baki J, Brown P, Tapper EB. Do Nutritional Interventions Improve the Outcomes of Patients with Cirrhosis and Ascites: A Systematic Review of Randomized Trials. Curr Hepatol Rep 2020;19:71-7. [PMID: 33473347 DOI: 10.1007/s11901-020-00513-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
74 Foster C, Baki J, Nikirk S, Williams S, Parikh ND, Tapper EB. Comprehensive Health-State Utilities in Contemporary Patients With Cirrhosis. Hepatol Commun 2020;4:852-8. [PMID: 32490321 DOI: 10.1002/hep4.1512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Trivella JP, Martin P, Carrion AF. Novel targeted therapies for the management of liver fibrosis. Expert Opinion on Emerging Drugs 2020;25:59-70. [DOI: 10.1080/14728214.2020.1735350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
76 Cohen-Mekelburg S, Waljee AK, Kenney BC, Tapper EB. Coordination of Care Is Associated With Survival and Health Care Utilization in a Population-Based Study of Patients With Cirrhosis. Clin Gastroenterol Hepatol 2020;18:2340-2348.e3. [PMID: 31927111 DOI: 10.1016/j.cgh.2019.12.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
77 Tapper EB, Hao S, Lin M, Mafi JN, McCurdy H, Parikh ND, Lok AS. The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers. Hepatology 2020;71:225-34. [PMID: 31063262 DOI: 10.1002/hep.30695] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
78 Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 2020;71:306-33. [PMID: 31314133 DOI: 10.1002/hep.30866] [Cited by in Crossref: 199] [Cited by in F6Publishing: 154] [Article Influence: 99.5] [Reference Citation Analysis]
79 Chen VL, Chen Y, Du X, Handelman SK, Speliotes EK. Genetic variants that associate with cirrhosis have pleiotropic effects on human traits. Liver Int. 2020;40:405-415. [PMID: 31815349 DOI: 10.1111/liv.14321] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
80 Winder GS, Fernandez AC, Klevering K, Mellinger JL. Confronting the Crisis of Comorbid Alcohol Use Disorder and Alcohol-Related Liver Disease With a Novel Multidisciplinary Clinic. Psychosomatics 2020;61:238-53. [PMID: 32033835 DOI: 10.1016/j.psym.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
81 Elsaid MI, Rustgi VK, Loo N, Aggarwal K, Li-mcleod J, Niu X, Poordad F. The burden associated with thrombocytopenia and platelet transfusions among patients with chronic liver disease. Journal of Medical Economics 2020;23:378-85. [DOI: 10.1080/13696998.2019.1699563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Bataller R, Cabezas J, Aller R, Ventura-Cots M, Abad J, Albillos A, Altamirano J, Arias-Loste MT, Bañares R, Caballería J, Caballería L, Carrión JA, Diago M, Fernández Rodríguez C, Gallego R, García-Cortes M, García-Monzón C, Genescà J, Ginés P, Hernandez-Guerra M, Jorquera F, Lligoña A, Molina E, Pareja MJ, Planas R, Tomé S, Salmerón J, Romero-Gómez M. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterol Hepatol 2019;42:657-76. [PMID: 31771785 DOI: 10.1016/j.gastrohep.2019.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Zou B, Yeo YH, Jeong D, Park H, Sheen E, Lee DH, Henry L, Garcia G, Ingelsson E, Cheung R, Nguyen MH. A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA. Dig Dis Sci 2020;65:1520-8. [PMID: 31598919 DOI: 10.1007/s10620-019-05869-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
84 Lucey MR. Alcohol-Associated Cirrhosis. Clin Liver Dis 2019;23:115-26. [PMID: 30454826 DOI: 10.1016/j.cld.2018.09.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
85 Dang K, Hirode G, Singal AK, Sundaram V, Wong RJ. Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases. Am J Gastroenterol 2020;115:96-104. [DOI: 10.14309/ajg.0000000000000380] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
86 Tapper EB, Henderson JB, Parikh ND, Ioannou GN, Lok AS. Incidence of and Risk Factors for Hepatic Encephalopathy in a Population-Based Cohort of Americans With Cirrhosis. Hepatol Commun 2019;3:1510-9. [PMID: 31701074 DOI: 10.1002/hep4.1425] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
87 Moscoso CG, Steer CJ. "Let my liver rather heat with wine" - a review of hepatic fibrosis pathophysiology and emerging therapeutics. Hepat Med 2019;11:109-29. [PMID: 31565001 DOI: 10.2147/HMER.S213397] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
88 Shen NT, Salajegheh A, Brown RS Jr. A Call to Standardize Definitions, Data Collection, and Outcome Assessment to Improve Care in Alcohol-Related Liver Disease. Hepatology 2019;70:1038-44. [PMID: 30802988 DOI: 10.1002/hep.30587] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
89 Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650-2666. [PMID: 31401364 DOI: 10.1016/j.cgh.2019.07.060] [Cited by in Crossref: 221] [Cited by in F6Publishing: 179] [Article Influence: 73.7] [Reference Citation Analysis]
90 Adejumo AC, Cholankeril G, Iqbal U, Yoo ER, Boursiquot BC, Concepcion WC, Kim D, Ahmed A. Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Dig Dis Sci 2020;65:990-1002. [PMID: 31372912 DOI: 10.1007/s10620-019-05759-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
91 Argemi J, Latasa MU, Atkinson SR, Blokhin IO, Massey V, Gue JP, Cabezas J, Lozano JJ, Van Booven D, Bell A, Cao S, Vernetti LA, Arab JP, Ventura-Cots M, Edmunds LR, Fondevilla C, Stärkel P, Dubuquoy L, Louvet A, Odena G, Gomez JL, Aragon T, Altamirano J, Caballeria J, Jurczak MJ, Taylor DL, Berasain C, Wahlestedt C, Monga SP, Morgan MY, Sancho-Bru P, Mathurin P, Furuya S, Lackner C, Rusyn I, Shah VH, Thursz MR, Mann J, Avila MA, Bataller R. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. Nat Commun 2019;10:3126. [PMID: 31311938 DOI: 10.1038/s41467-019-11004-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
92 Orman ES, Roberts A, Ghabril M, Nephew L, Desai AP, Patidar K, Chalasani N. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis. JAMA Netw Open 2019;2:e196412. [PMID: 31251379 DOI: 10.1001/jamanetworkopen.2019.6412] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
93 Volk ML, Lucey MR. Alcoholic Liver Disease: Policy and Practice. Clinical Liver Disease 2019;13:117-117. [DOI: 10.1002/cld.775] [Reference Citation Analysis]
94 Mellinger JL. Epidemiology of Alcohol Use and Alcoholic Liver Disease.Clin Liver Dis (Hoboken). 2019;13:136-139. [PMID: 31236261 DOI: 10.1002/cld.806] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
95 Mellinger JL. Spotlight on Impactful Research: Universal Screening for Alcohol Misuse in Acute Admissions Is Feasible and Identifies Patients at High Risk for Liver Disease. Clin Liver Dis (Hoboken) 2018;12:83-4. [PMID: 30988917 DOI: 10.1002/cld.731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Konerman MA, Rogers M, Kenney B, Singal AG, Tapper E, Sharma P, Saini S, Nallamothu B, Waljee A. Opioid and benzodiazepine prescription among patients with cirrhosis compared to other forms of chronic disease. BMJ Open Gastroenterol 2019;6:e000271. [PMID: 31139424 DOI: 10.1136/bmjgast-2018-000271] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
97 Shen NT, Londono C, Gold S, Wu A, Mages KC, Brown RSJ. Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes. World J Gastroenterol 2019; 25(13): 1628-1639 [PMID: 30983822 DOI: 10.3748/wjg.v25.i13.1628] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
98 Baki JA, Tapper EB. Contemporary Epidemiology of Cirrhosis. Curr Treat Options Gastroenterol 2019;17:244-53. [PMID: 30949926 DOI: 10.1007/s11938-019-00228-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
99 Volk ML, Mellinger J, Bansal MB, Gellad ZF, McClellan M, Kanwal F. A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis. Hepatology 2019;69:1300-5. [PMID: 30226642 DOI: 10.1002/hep.30277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
100 Mellinger JL, Fernandez A, Shedden K, Winder GS, Fontana RJ, Volk ML, Blow FC, Lok ASF. Gender Disparities in Alcohol Use Disorder Treatment Among Privately Insured Patients with Alcohol-Associated Cirrhosis. Alcohol Clin Exp Res 2019;43:334-41. [PMID: 30667521 DOI: 10.1111/acer.13944] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
101 Mancina RM, Ferri F, Farcomeni A, Molinaro A, Maffongelli A, Mischitelli M, Poli E, Parlati L, Burza MA, De Santis A, Attilia F, Rotondo C, Rando MM, Attilia ML, Ceccanti M, Ginanni Corradini S. A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption. Appl Clin Genet 2019;12:1-10. [PMID: 30666147 DOI: 10.2147/TACG.S187922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
102 Ezaz G, Tapper EB. Driving in the dark: cirrhosis in young adults. Lancet Gastroenterol Hepatol 2019;4:189-90. [PMID: 30573391 DOI: 10.1016/S2468-1253(18)30419-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Grucza RA, Sher KJ, Kerr WC, Krauss MJ, Lui CK, McDowell YE, Hartz S, Virdi G, Bierut LJ. Trends in Adult Alcohol Use and Binge Drinking in the Early 21st-Century United States: A Meta-Analysis of 6 National Survey Series. Alcohol Clin Exp Res 2018;42:1939-50. [PMID: 30080258 DOI: 10.1111/acer.13859] [Cited by in Crossref: 99] [Cited by in F6Publishing: 85] [Article Influence: 24.8] [Reference Citation Analysis]
104 Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ 2018;362:k2817. [PMID: 30021785 DOI: 10.1136/bmj.k2817] [Cited by in Crossref: 248] [Cited by in F6Publishing: 247] [Article Influence: 62.0] [Reference Citation Analysis]